Michael Scolaro

Michael Scolaro

Nov 19, 2017

Group 6 Copy 212
0
    Please wait...

    About This Project

    We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

    Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Improving the detection of expired medication in developing countries to improve maternal health

    Oxytocin prevents maternal mortality by reducing bleeding after giving birth. It's limited in rural areas...

    Investigating the epidemiology of elephant endotheliotropic herpesvirus in Myanmar

    Elephant endotheliotropic herpesvirus hemorrhagic disease (EEHV-HD) is the leading cause of death of young...

    Are coyotes contributing to the spread Rocky Mountain spotted fever in Arizona?

    Rocky Mountain spotted fever (RMSF) is a tick-borne bacterial infection that can cause permanent disability...

    Backer Badge Funded